Literature DB >> 28759709

Reconstruction method as an independent risk factor for postoperative bone mineral density loss in gastric cancer.

Taisuke Imamura1, Shuhei Komatsu1, Daisuke Ichikawa1, Toshiyuki Kosuga1, Takeshi Kubota1, Kazuma Okamoto1, Hirotaka Konishi1, Atsushi Shiozaki1, Hitoshi Fujiwara1, Eigo Otsuji1.   

Abstract

BACKGROUND AND AIM: No study has compared the incidence of postoperative bone metabolic disorders between Billroth-I (B-I) and Roux-en-Y (R-Y) reconstructions after distal gastrectomy (DG) for gastric cancer (GC). In this study, we wished to examine the impact of reconstruction method on postoperative bone mineral density (BMD) loss.
METHODS: We investigated a total of 148 consecutive patients who underwent DG with B-I or R-Y reconstruction for stage I GC between 2008 and 2012. We retrospectively assessed the BMD data using computed tomography attenuation values of the first lumbar vertebra after surgery.
RESULTS: In multivariate analysis for the whole study series, R-Y reconstruction was identified as an independent risk factor for BMD loss after DG (P < 0.0001; OR = 5.60; 95% CI = 2.38-13.98). Propensity score match analysis was used to overcome bias because of the different covariates for the two groups; even though the 37 patients in the B-I group and the 37 patients in the R-Y group had no significant difference among characteristics, B-I reconstruction was validated to have superiority over R-Y reconstruction for preventing BMD loss in the first 3 years after DG. The cumulative hazard ratio of osteoporosis after gastrectomy was significantly higher in the R-Y group than in the B-I group (P = 0.0427).
CONCLUSIONS: Billroth-I reconstruction might be a preferable method for preventing BMD loss after gastrectomy in GC patients.
© 2017 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  Billroth-I reconstruction; CT attenuation value; Roux-en-Y reconstruction; bone mineral density; gastric cancer

Mesh:

Year:  2018        PMID: 28759709     DOI: 10.1111/jgh.13910

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  5 in total

1.  Incidence and risk factors of osteoporotic status in outpatients who underwent gastrectomy for gastric cancer.

Authors:  Tsutomu Namikawa; Keiichiro Yokota; Jun Iwabu; Masaya Munekage; Sunao Uemura; Shigehiro Tsujii; Hiromichi Maeda; Hiroyuki Kitagawa; Takashi Karashima; Masamitsu Kumon; Keiji Inoue; Michiya Kobayashi; Kazuhiro Hanazaki
Journal:  JGH Open       Date:  2020-04-23

Review 2.  Metabolic bone disorders after gastrectomy: inevitable or preventable?

Authors:  Yasushi Rino; Toru Aoyama; Yosuke Atsumi; Takanobu Yamada; Norio Yukawa
Journal:  Surg Today       Date:  2021-02-25       Impact factor: 2.549

3.  Laparoscopic spleen-preserving distal versus central pancreatectomy for tumors in the pancreatic neck and proximal body.

Authors:  Hao Zhang; Qiaoyu Xu; Chunlu Tan; Xing Wang; Bing Peng; Xubao Liu; Kezhou Li
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

Review 4.  Bone Fragility in Gastrointestinal Disorders.

Authors:  Daniela Merlotti; Christian Mingiano; Roberto Valenti; Guido Cavati; Marco Calabrese; Filippo Pirrotta; Simone Bianciardi; Alberto Palazzuoli; Luigi Gennari
Journal:  Int J Mol Sci       Date:  2022-02-28       Impact factor: 5.923

Review 5.  Essential updates 2017/2018: Recent topics in the treatment and research of gastric cancer in Japan.

Authors:  Shuhei Komatsu; Eigo Otsuji
Journal:  Ann Gastroenterol Surg       Date:  2019-08-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.